331 related articles for article (PubMed ID: 18353542)
1. Ceramide-induced cell death in malignant cells.
Carpinteiro A; Dumitru C; Schenck M; Gulbins E
Cancer Lett; 2008 Jun; 264(1):1-10. PubMed ID: 18353542
[TBL] [Abstract][Full Text] [Related]
2. Biological aspects of ceramide-enriched membrane domains.
Grassmé H; Riethmüller J; Gulbins E
Prog Lipid Res; 2007; 46(3-4):161-70. PubMed ID: 17490747
[TBL] [Abstract][Full Text] [Related]
3. Targeting the ceramide system in cancer.
Henry B; Möller C; Dimanche-Boitrel MT; Gulbins E; Becker KA
Cancer Lett; 2013 May; 332(2):286-94. PubMed ID: 21862212
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of ceramide in lipid-rich microdomains (rafts): antagonistic role of palmitoyl:protein thioesterase and neutral sphingomyelinase 2.
Goswami R; Ahmed M; Kilkus J; Han T; Dawson SA; Dawson G
J Neurosci Res; 2005 Jul; 81(2):208-17. PubMed ID: 15929065
[TBL] [Abstract][Full Text] [Related]
5. Bacterial infections and ceramide.
Grassmé H; Becker KA
Handb Exp Pharmacol; 2013; (216):305-20. PubMed ID: 23563663
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin-induced CD95 redistribution into membrane lipid rafts of HT29 human colon cancer cells.
Lacour S; Hammann A; Grazide S; Lagadic-Gossmann D; Athias A; Sergent O; Laurent G; Gambert P; Solary E; Dimanche-Boitrel MT
Cancer Res; 2004 May; 64(10):3593-8. PubMed ID: 15150117
[TBL] [Abstract][Full Text] [Related]
7. TRAIL activates acid sphingomyelinase via a redox mechanism and releases ceramide to trigger apoptosis.
Dumitru CA; Gulbins E
Oncogene; 2006 Sep; 25(41):5612-25. PubMed ID: 16636669
[TBL] [Abstract][Full Text] [Related]
8. Raft ceramide in molecular medicine.
Gulbins E; Kolesnick R
Oncogene; 2003 Oct; 22(45):7070-7. PubMed ID: 14557812
[TBL] [Abstract][Full Text] [Related]
9. Ceramide in chemotherapy of tumors.
Dimanche-Boitrel MT; Rebillard A; Gulbins E
Recent Pat Anticancer Drug Discov; 2011 Sep; 6(3):284-93. PubMed ID: 21762073
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin enhances TRAIL-induced cell death via ceramide-enriched membrane platforms.
Dumitru CA; Carpinteiro A; Trarbach T; Hengge UR; Gulbins E
Apoptosis; 2007 Aug; 12(8):1533-41. PubMed ID: 17520194
[TBL] [Abstract][Full Text] [Related]
11. [Sphingolipid-mediated apoptotic signaling pathways].
Cuvillier O; Andrieu-Abadie N; Ségui B; Malagarie-Cazenave S; Tardy C; Bonhoure E; Levade T
J Soc Biol; 2003; 197(3):217-21. PubMed ID: 14708343
[TBL] [Abstract][Full Text] [Related]
12. Ceramide synthesis and metabolism as a target for cancer therapy.
Reynolds CP; Maurer BJ; Kolesnick RN
Cancer Lett; 2004 Apr; 206(2):169-80. PubMed ID: 15013522
[TBL] [Abstract][Full Text] [Related]
13. De novo C16- and C24-ceramide generation contributes to spontaneous neutrophil apoptosis.
Seumois G; Fillet M; Gillet L; Faccinetto C; Desmet C; François C; Dewals B; Oury C; Vanderplasschen A; Lekeux P; Bureau F
J Leukoc Biol; 2007 Jun; 81(6):1477-86. PubMed ID: 17329567
[TBL] [Abstract][Full Text] [Related]
14. Ceramide-enriched membrane domains in infectious biology and development.
Becker KA; Gellhaus A; Winterhager E; Gulbins E
Subcell Biochem; 2008; 49():523-38. PubMed ID: 18751925
[TBL] [Abstract][Full Text] [Related]
15. Ceramide-enriched membrane domains.
Bollinger CR; Teichgräber V; Gulbins E
Biochim Biophys Acta; 2005 Dec; 1746(3):284-94. PubMed ID: 16226325
[TBL] [Abstract][Full Text] [Related]
16. De novo ceramide synthesis is responsible for the anti-tumor properties of camptothecin and doxorubicin in follicular thyroid carcinoma.
Rath G; Schneider C; Langlois B; Sartelet H; Morjani H; Btaouri HE; Dedieu S; Martiny L
Int J Biochem Cell Biol; 2009 May; 41(5):1165-72. PubMed ID: 19027085
[TBL] [Abstract][Full Text] [Related]
17. Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts.
Grassmé H; Jendrossek V; Riehle A; von Kürthy G; Berger J; Schwarz H; Weller M; Kolesnick R; Gulbins E
Nat Med; 2003 Mar; 9(3):322-30. PubMed ID: 12563314
[TBL] [Abstract][Full Text] [Related]
18. Ceramide: physiological and pathophysiological aspects.
Schenck M; Carpinteiro A; Grassmé H; Lang F; Gulbins E
Arch Biochem Biophys; 2007 Jun; 462(2):171-5. PubMed ID: 17467652
[TBL] [Abstract][Full Text] [Related]
19. Ceramide-mediated clustering is required for CD95-DISC formation.
Grassmé H; Cremesti A; Kolesnick R; Gulbins E
Oncogene; 2003 Aug; 22(35):5457-70. PubMed ID: 12934106
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of ceramide-mediated CD95 clustering.
Grassmé H; Schwarz H; Gulbins E
Biochem Biophys Res Commun; 2001 Jun; 284(4):1016-30. PubMed ID: 11409897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
